Therapeutic Efficacy of Liposomal Rifabutin in a Mycobacterium avium Model of Infection
Liposomal formulations of rifabutin were developed, and the effects of some parameters on the incorporation efficiency were studied. The antimycobacterial activity of rifabutin incorporated into liposomes prepared with phosphatidylcholine and phosphatidylserine (molar ratio, 7:3) was evaluated in a...
Guardat en:
| Publicat a: | Antimicrob Agents Chemother |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society for Microbiology (ASM)
2000
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90080/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10952590/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.44.9.2424-2430.2000 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
